Clinical trial
A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With…
NCT03320304 · LivaNova, Industry · Recruiting
Key facts
| NCT number | NCT03320304 |
|---|---|
| Title | A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression. |
| Official title | A Global PRospective, Multi-cEnter, ObServational Post-markeT Study tO Assess shoRt, Mid and Long-term Effectiveness and Efficiency of VNS Therapy® as Adjunctive Therapy in reaL-world patIents With diFficult to Treat dEpression. |
| Acronym | RESTORE-LIFE |
| Lead sponsor | LivaNova, Industry |
| Status | Recruiting |
| Study type | Observational [Patient Registry] |
| Conditions | Treatment Resistant Depression |
| Intervention type | Device |
| Interventions | Vagal Nerve Simulation (VNS) Therapy |
| Enrollment | 500 |
| Start date | Dec 14, 2017 |
| Primary completion | Dec 1, 2029 |
| Completion | Dec 1, 2031 |
| First posted | Oct 25, 2017 |
| Last update posted | Jan 26, 2026 |
| Countries | Austria, Belgium, Germany, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: